Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

North China Pharmaceutical Co Ltd Adjusts Private Placement Plan


Tuesday, 20 Aug 2013 08:00pm EDT 

North China Pharmaceutical Co Ltd announced that it has adjusted its private placement plan of issuing up to 250,000,000 A shares of common stock with par value of RMB 1 per share at RMB 4.53 per share, due to the Company's dividend payment of RMB 0.37 per 10 shares (pre-tax) for fiscal year 2012. According to the new plan, the Company will issue 252,227,171 A shares at RMB 4.49 per share. 

Company Quote

6.67
0.17 +2.62%
5 Mar 2015